drug · small molecule
patient view →Oral Psilocybin
Phase 2updated 2mo agoby Revive Therapeutics Ltd🔗 ChEMBL
Phase 2community read0 votes
Small molecule drug with a maximum clinical stage of Phase 3 (across all indications), with 35 investigational indications.
targets
5-hydroxytryptamine receptor 2A
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that